Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Breast Cancer Research : BCR|February 26, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancerRebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
NPJ Breast Cancer|August 4, 2021
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registryYash S Huilgol, Holly Keane, Yiwey Shieh, et al.
Breast Cancer Research and Treatment|November 19, 2022
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancerAditya Bardia, Ingrid Mayer, Eric Winer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trialEllen B Gold, John P Pierce, Loki Natarajan, et al.
Cancer Discovery|January 6, 2025
The Hallmarks of Predictive OncologyAkshat Singhal, Xiaoyu Zhao, Patrick Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid TumorsNeelima Vidula, Thereasa A Rich, Oliver Sartor, et al.
The Journal of Nutrition|September 22, 2007
Telephone counseling helps maintain long-term adherence to a high-vegetable dietary patternJohn P Pierce, Vicky A Newman, Loki Natarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2013
Developing safety criteria for introducing new agents into neoadjuvant trialsAngela DeMichele, Donald A Berry, JoAnne Zujewski, et al.
JAMA|July 20, 2007
Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trialJohn P Pierce, Loki Natarajan, Bette J Caan, et al.
Pageof 10